Par Pharmaceutical Companies' Take Private Round

Par Pharmaceutical Companies raised a round of funding on July 16, 2012. Investors include TPG Capital.

Par Pharmaceutical Companies is a privately held, U.S.-based specialty pharmaceutical company. The company develops, manufactures and markets high-barrier-to-entry generic drugs and niche, innovative …

Articles about Par Pharmaceutical Companies' Take Private Round: